259 related articles for article (PubMed ID: 38318504)
21. High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing.
Montero-Martín G; Mallempati KC; Gangavarapu S; Sánchez-Gordo F; Herrero-Mata MJ; Balas A; Vicario JL; Sánchez-García F; González-Escribano MF; Muro M; Moya-Quiles MR; González-Fernández R; Ocejo-Vinyals JG; Marín L; Creary LE; Osoegawa K; Vayntrub T; Caro-Oleas JL; Vilches C; Planelles D; Fernández-Viña MA
Hum Immunol; 2019 Jul; 80(7):429-436. PubMed ID: 30763600
[TBL] [Abstract][Full Text] [Related]
22. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
[TBL] [Abstract][Full Text] [Related]
23. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
[TBL] [Abstract][Full Text] [Related]
24. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
25. Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.
Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
PLoS One; 2010 Jul; 5(7):e11806. PubMed ID: 20668555
[TBL] [Abstract][Full Text] [Related]
26. Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles.
Degenhardt F; Wendorff M; Wittig M; Ellinghaus E; Datta LW; Schembri J; Ng SC; Rosati E; Hübenthal M; Ellinghaus D; Jung ES; Lieb W; Abedian S; Malekzadeh R; Cheon JH; Ellul P; Sood A; Midha V; Thelma BK; Wong SH; Schreiber S; Yamazaki K; Kubo M; Boucher G; Rioux JD; Lenz TL; Brant SR; Franke A
Hum Mol Genet; 2019 Jun; 28(12):2078-2092. PubMed ID: 30590525
[TBL] [Abstract][Full Text] [Related]
27. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
29. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
[TBL] [Abstract][Full Text] [Related]
30. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
[TBL] [Abstract][Full Text] [Related]
31. Human Leukocyte Antigen (HLA) Class I and II Polymorphism in Iranian Healthy Population from Yazd Province.
Nikbin B; Nicknam MH; Hadinedoushan H; Ansaripour B; Moradi B; Yekaninejad M; Aminikhah M; Ranjbar MM; Amirzargar A
Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):1-13. PubMed ID: 28417619
[TBL] [Abstract][Full Text] [Related]
32. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes.
Carrington M; Colonna M; Spies T; Stephens JC; Mann DL
Immunogenetics; 1993; 37(4):266-73. PubMed ID: 8267790
[TBL] [Abstract][Full Text] [Related]
33. HLA diversity, differentiation, and haplotype evolution in Mesoamerican Natives.
Hollenbach JA; Thomson G; Cao K; Fernandez-Vina M; Erlich HA; Bugawan TL; Winkler C; Winter M; Klitz W
Hum Immunol; 2001 Apr; 62(4):378-90. PubMed ID: 11295471
[TBL] [Abstract][Full Text] [Related]
34. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
35. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
Tsai YY; Qu C; Bonner JD; Sanz-Pamplona R; Lindsey SS; Melas M; McDonnell KJ; Idos GE; Walker CP; Tsang KK; Da Silva DM; Moratalla-Navarro F; Maoz A; Rennert HS; Kast WM; Greenson JK; Moreno V; Rennert G; Gruber SB; Schmit SL
Front Immunol; 2023; 14():1268117. PubMed ID: 37942321
[TBL] [Abstract][Full Text] [Related]
36. Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans.
Fang H; Shen S; Zheng X; Dang E; Zhang J; Shao S; Qiao P; Li Q; Wang H; Li C; Sun L; Wang G
J Dermatol Sci; 2018 Mar; 89(3):258-262. PubMed ID: 29248402
[TBL] [Abstract][Full Text] [Related]
37. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
[TBL] [Abstract][Full Text] [Related]
38. HLA class II immunogenetics and incidence of insulin-dependent diabetes mellitus in the population of Cantabria (Northern Spain).
Escribano-de-Diego J; Sánchez-Velasco P; Luzuriaga C; Ocejo-Vinyals JG; Paz-Miguel JE; Leyva-Cobián F
Hum Immunol; 1999 Oct; 60(10):990-1000. PubMed ID: 10566601
[TBL] [Abstract][Full Text] [Related]
39. Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.
Iafolla MAJ; Yang C; Chandran V; Pintilie M; Li Q; Bedard PL; Hansen A; Lheureux S; Spreafico A; Razak AA; Hakgor S; Giesler A; Pugh TJ; Siu LL
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554038
[TBL] [Abstract][Full Text] [Related]
40. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
